Senior Member, Department of Cutaneous Oncology, Moffitt Cancer Center Professor of Surgery and Oncologic Sciences, USF-Morsani College of Medicine
General Surgery
Dr. Jonathan S. Zager, MD
|
|
Give Review
Jonathan Zager works in the field of General Surgery. He went to Albert Einstein College of Medicine. He received awards:"Best Doctors in America", "Americas Top Surgeons", "Patients Choice Award", "Whos Who in Medicine and Healthcare", "Most Compassionate Doctor" and "Fellow (FACS)". Jonathan S. Zager has written publications. He has 101 publications published with PubMed. The lastest paper is: 'Developments in Intralesional Therapy for Metastatic Melanoma.' Doctor Jonathan S. Zager, MD accepts Medicare payments and is registered with Medicare.gov.
Publications
- Is a Wider Margin (2 cm vs. 1 cm) for a 1.01-2.0 mm Melanoma Necessary?
- BRAF inhibition for advanced locoregional BRAF V600E mutant melanoma: a potential neoadjuvant strategy.
- BRAF and MEK inhibition in melanoma.
- Sentinel Lymph Node Mapping in Melanoma in the Twenty-first Century.
- Sentinel lymph node biopsy is indicated for patients with thick clinically lymph node-negative melanoma.
- A multicenter phase I dose escalation trial to evaluate safety and tolerability of intra-arterial temozolomide for patients with advanced extremity melanoma using norm...
- Regional therapy in metastatic melanoma: an update on minimally invasive intraarterial isolated limb infusion and perCutaneous hepatic perfusion.
- Locoregional Therapies in Melanoma.
- Burden of Disease Predicts Response to Isolated Limb Infusion with Melphalan and Actinomycin D in Melanoma.
- Occult primary, version 3.2014.
- Melanoma: MSLT-1-putting sentinel lymph node biopsy into context.
- Chemosaturation with perCutaneous hepatic perfusion for unresectable metastatic melanoma or sarcoma to the liver: a single institution experience.
- Metastatic melanoma to the liver: a contemporary and comprehensive review of surgical, Systemic, and regional therapeutic options.
- Recent developments in the medical and surgical treatment of melanoma.
- A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trialof Lovastatin for Various Endpoints of Melanoma Pathobiology.
- Unanswered Questions in the Management of Stage I-III Merkel Cell Carcinoma.
- Analysis of Tumor Mitotic Rate in Thin Metastatic Melanomas Compared With Thin Melanomas Without Metastasis Using Both the Hematoxylin and Eosin and Anti-phosphohiston...
- Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma.
- Isolated hepatic perfusion for metastatic melanoma.
- Resection of Residual Disease after Isolated Limb Infusion (ILI) Is Equivalent to a Complete Response after ILI-Alone in Advanced Extremity Melanoma.
- Radiotherapy influences local control in patients with desmoplastic melanoma.
- Cutaneous leiomyosarcoma: treatment and outcomes with a standardized margin of resection.
- Identifying risk factors using a skin Cancer screening program.
- Recent advances in the treatment of melanoma.
- Pediatric melanoma: Analysis of an international registry.
- Cutaneous Angiosarcoma: A Single-Institution Experience.
- Controversies in the evaluation and management of atypical melanocytic proliferations in children, adolescents, and young adults.
- Single-institution Outcome Experience Using AlloDerm® as Temporary Coverage or Definitive Reconstruction for Cutaneous and Soft Tissue Malignancy Defects.
- Clinical development of dabrafenib in BRAF mutant melanoma and other malignancies.
- A collision of diseases: chronic lymphocytic Leukemia discovered during lymph node biopsy for melanoma.
- Isolated limb infusion in a series of over 100 infusions: a single-center experience.
- Telomere length and risk of melanoma, squamous cell carcinoma, and Basal cell carcinoma.
- Desmoplastic Melanoma: Is There a Role for Sentinel Lymph Node Biopsy?
- Combined Analysis of Phase III Trials Evaluating [(99m)Tc]Tilmanocept and Vital Blue Dye for Identification of Sentinel Lymph Nodes in Clinically Node-Negative Cutaneo...
- Chemosaturation with perCutaneous hepatic perfusion for unresectable isolated hepatic metastases from sarcoma.
- The use of isolated limb infusion in limb threatening extremity Sarcomas.
- A multi-institution experience comparing the clinical and physiologic differences between upper extremity and lower extremity melphalan-based isolated limb infusion.
- A comparison between patients with gastroIntestinal stromal tumours diagnosed with isolated liver metastases and liver metastases plus sarcomatosis.
- The unique clinical characteristics of melanoma diagnosed in children.
- Progression of Cutaneous melanoma: implications for treatment.
- Sentinel node biopsy is indicated for thin melanomas ≥0.76 mm.
- Efficacy of adoptive Cell transfer of tumor-infiltrating lymphocytes after lymphopenia induction for metastatic melanoma.
- Primary tumor thickness as a prognostic factor in Merkel Cell carcinoma: the next big thing?
- A multicenter prospective evaluation of the clinical utility of F-18 FDG-PET/CT in patients with AJCC stage IIIB or IIIC extremity melanoma.
- Merkel Cell carcinoma of unknown primary origin.
- A multi-institutional experience of repeat regional chemotherapy for recurrent melanoma of extremities.
- Preoperative ultrasound is not useful for identifying nodal metastasis in melanoma patients undergoing sentinel node biopsy: preoperative ultrasound in clinically node...
- Isolated regional therapy for advanced extremity soft tissue Sarcomas.
- Sentinel node biopsy in atypical melanocytic neoplasms in childhood: a single institution experience in 24 patients.
- Combination of external beam radiotherapy (EBRT) with intratumoral injection of dendritic Cells as neo-adjuvant treatment of high-risk soft tissue sarcoma patients.
- The role of radical amputations for extremity tumors: a single institution experience and review of the literature.
- Occult primary.
- Profound proliferating angiolymphoid hyperplasia with eosinophilia of pregnancy mimicking angioSarcoma.
- Minimally invasive intra-arterial regional therapy for metastatic melanoma: isolated limb infusion and perCutaneous hepatic perfusion.
- What is the significance of the in transit or interval sentinel node in melanoma?
- Limb preservation with isolated limb infusion for locally advanced nonmelanoma Cutaneous and soft-tissue malignant neoplasms.
- Strategies for solutions in Sarcoma management.
- Current diagnosis and management of retroperitoneal Sarcoma.
- Prognostication in Merkel Cell carcinoma.
- Shave biopsy is a safe and accurate method for the initial evaluation of melanoma.
- Prospective multicenter phase II trial of Systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with advanced extremity melanoma.
- Surgically unresectable regional melanoma metastases in a patient with renal failure and peripheral vascular Disease: are there safe and potentially effective treatments?
- Routine biopsy of Cloquet's node is of limited value in sentinel node positive melanoma patients.
- Isolated limb infusion for melanoma: a less morbid alternative to hyperthermic isolated limb perfusion in the US.
- DermatofibroSarcoma protuberans: how wide should we resect?
- Merkel Cell carcinoma: pathologic findings and prognostic factors.
- The surgical management of primary and metastatic Merkel Cell carcinoma.
- Who is to blame for false-negative sentinel node biopsies in melanoma?
- Pathology review of thin melanoma and melanoma in Situ in a multidisciplinary melanoma clinic: impact on treatment decisions.
- Routine omission of sentinel lymph node biopsy for merkel Cell carcinoma <= 1 cm is not justified.
- Commentary on pharmacotherapy of regional melanoma therapy.
- Predictive factors of regional toxicity and serum creatine phosphokinase levels after isolated limb infusion for melanoma: a multi-institutional Analysis.
- Melanoma: promising new discoveries and treatment modalities for difficult clinical scenarios - part II.
- Sentinel lymph node biopsy for melanoma: indications and rationale.
- Limiting the morbidity of Inguinal lymphadenectomy for metastatic melanoma.
- Surgical management of melanoma-in-Situ using a staged marginal and central excision technique.
- A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US.
- Multimodality management of desmoid tumors: how important is a negative surgical margin?
- Proper margins of excision in dermatofibroSarcoma protuberans: wide or narrow?
- Melanoma: promising new discoveries and treatment modalities for difficult clinical scenarios.
- Therapy for unresectable recurrent and in-transit extremity melanoma.
- Treatment options for limited or symptomatic metastatic melanoma.
- Full-thickness grafts procured from skin overlying the sentinel lymph node basin; reconstruction of primary Cutaneous malignancy excision defects.
- Toxicities associated with hyperthermic isolated limb perfusion and isolated limb infusion in the treatment of melanoma and Sarcoma.
- Multidisciplinary management of special melanoma Situations: oligometastatic disease and bulky nodal sites.
- Sentinel lymph node biopsy as the standard of care for Cutaneous melanoma.
- Cytoreductive surgery for melanoma.
- Pelvic exenteration affords safe and durable treatment for locally advanced Rectal carcinoma.
- Use of an oncolytic virus secreting GM-CSF as combined oncolytic and immunotherapy for treatment of coloRectal and hepatic adenocarcinomas.
- Clinical challenges presented by three simultaneous solid tumors.
- The role of ultrasound in the surgical management of patients diagnosed with ductal Carcinoma in situ of the breast.
- Treatment of cholangioCarcinoma with oncolytic herpes simplex virus combined with external beam radiation therapy.
- Lymphatic mapping and sentinel node biopsy: a surgical perspective.
- Effect of murine liver Cell proliferation on herpes viral behavior: implications for oncolytic viral therapy.
- Up-regulation of GADD34 mediates the synergistic antiCancer activity of mitomycin C and a gamma134.5 deleted oncolytic herpes virus (G207).
- Intussusception: an uncommon cause of postoperative small bowel Obstruction after gastric bypass.
- Endovascular repair of a traumatic pseudoaneurysm of the thoracic aorta in a patient with concomitant intracranial and intra-abdominal injuries.
- Use of radiolabelled iododeoxyuridine as adjuvant treatment for experimental tumours of the liver.
- Developments in Intralesional Therapy for Metastatic Melanoma.
- Art, Science, and Personalized Cancer Care Through Regional Therapeutics.
Schools
Sackler School Of Medicine Tel Aviv University
N Shore University Hospital
Montefiore Med Center
MD Anderson Canc Institute University Tex
Meml Sloan Kettering Canc Center
University Of Massachusetts
Procedures Preformed
- Adrenalectomy
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Colectomy
- Enterostomy (Laparoscopic or Open)
- View All
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- General Surgery
- Surgical Oncology
Accepted Insurances
Awards
- Best Doctors in America
- Americas Top Surgeons
- Patients Choice Award
- Whos Who in Medicine and Healthcare
- Most Compassionate Doctor
- Fellow (FACS)
Education
-
University of Texas MD Anderson Cancer Center -
Albert Einstein College of Medicine -
Memorial Sloan-Kettering Cancer Center -
North Shore-Long Island Jewish Health System -
Tel Aviv University Sackler
Hospital
-
H. Lee Moffitt Cancer Center and Research Institute
Drug Facts
| NPI NUMBER | 1629080304 | |
| NPPES Provider LastName | ZAGER | |
| NPPES Provider FirstName | JONATHAN | |
| NPPES Provider ZIPCode | 336129416 | |
| NPPES Provider State | FL | |
| Specialty Description | General Surgery | |
| Total Claim Count | 67.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 34.0 | |
| Percent Opioid Claims | 50.75 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1629080304 |
| Last Name Of The Provider | ZAGER |
| First Name Of The Provider | JONATHAN |
| View All |
Similar Doctors
|
Dr. Jacob Gerzenshtein, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. John M. Cox, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Michael G. Siegman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Philip H. Andersen, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. John A. Dietrick III, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Michael H. Albrink, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert J. Heller, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hideko Yamauchi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. N S. Lynn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dennis A. Alfonso, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter A. Jarvis, MD
This Doctor is OpenDoctor Recommended.
|